tiprankstipranks
Trending News
More News >
Kaleido Biosciences Inc (KLDO)
OTHER OTC:KLDO
US Market

Kaleido Biosciences (KLDO) Ratios

Compare
198 Followers

Kaleido Biosciences Ratios

KLDO's free cash flow for Q4 2021 was $1.00. For the 2021 fiscal year, KLDO's free cash flow was decreased by $ and operating cash flow was $-39.75. See a summary of the company’s cash flow.
Ratios
TTM
Dec 21Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio
1.43 2.77 7.06--
Quick Ratio
1.43 2.77 7.06--
Cash Ratio
1.30 2.77 6.87--
Solvency Ratio
-2.22 -2.01 -2.50--
Operating Cash Flow Ratio
-2.60 -3.69 -7.30--
Short-Term Operating Cash Flow Coverage
-4.78 -23.36 0.00--
Net Current Asset Value
$ 2.78M$ 7.37M$ 39.86M--
Leverage Ratios
Debt-to-Assets Ratio
0.43 0.35 0.25--
Debt-to-Equity Ratio
2.05 1.03 0.42--
Debt-to-Capital Ratio
0.67 0.51 0.30--
Long-Term Debt-to-Capital Ratio
0.34 0.47 0.29--
Financial Leverage Ratio
4.73 2.90 1.68--
Debt Service Coverage Ratio
-4.48 -13.83 -87.35--
Interest Coverage Ratio
-30.89 -28.15 -88.70--
Debt to Market Cap
5.09K 0.07 0.16--
Interest Debt Per Share
0.59 0.71 0.83--
Net Debt to EBITDA
0.20 0.33 0.59--
Profitability Margins
Gross Profit Margin
-113.59%94.26%0.00%--
EBIT Margin
-7921.20%-8083.90%0.00%--
EBITDA Margin
-7707.61%-7896.92%0.00%--
Operating Profit Margin
-7940.85%-8089.64%0.00%--
Pretax Profit Margin
-8178.26%-8371.18%0.00%--
Net Profit Margin
-8178.26%-8184.21%0.00%--
Continuous Operations Profit Margin
-8178.26%-8371.28%0.00%--
Net Income Per EBT
100.00%97.77%98.47%--
EBT Per EBIT
102.99%103.48%99.62%--
Return on Assets (ROA)
-180.08%-134.46%-103.29%--
Return on Equity (ROE)
-580.57%-389.32%-173.91%--
Return on Capital Employed (ROCE)
-428.58%-184.78%-120.48%--
Return on Invested Capital (ROIC)
-239.53%-170.15%-118.53%--
Return on Tangible Assets
-172.05%-129.15%-103.29%--
Earnings Yield
-2156904.33%-26.21%-65.89%--
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00--
Payables Turnover
0.42 0.01 0.65--
Inventory Turnover
0.00 0.00 0.00--
Fixed Asset Turnover
0.19 0.12 0.00--
Asset Turnover
0.02 0.02 0.00--
Working Capital Turnover Ratio
0.05 0.02 0.00--
Cash Conversion Cycle
-877.67 -35.15K -558.30--
Days of Sales Outstanding
0.00 0.00 0.00--
Days of Inventory Outstanding
0.00 0.00 0.00--
Days of Payables Outstanding
877.67 35.15K 558.30--
Operating Cycle
0.00 0.00 0.00--
Cash Flow Ratios
Operating Cash Flow Per Share
-1.84 -1.84 -2.95--
Free Cash Flow Per Share
-1.87 -1.96 -3.09--
CapEx Per Share
0.03 0.12 0.14--
Free Cash Flow to Operating Cash Flow
1.01 1.07 1.05--
Dividend Paid and CapEx Coverage Ratio
-68.29 -15.29 -21.14--
Capital Expenditure Coverage Ratio
-68.29 -15.29 -21.14--
Operating Cash Flow Coverage Ratio
-3.55 -2.93 -3.70--
Operating Cash Flow to Sales Ratio
-69.83 -63.10 0.00--
Free Cash Flow Yield
-1835358.99%-21.53%-61.52%--
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -3.81 -1.52--
Price-to-Sales (P/S) Ratio
<0.01 312.20 0.00--
Price-to-Book (P/B) Ratio
<0.01 14.85 2.64--
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -4.64 -1.63--
Price-to-Operating Cash Flow Ratio
>-0.01 -4.95 -1.70--
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.14 -0.03--
Price-to-Fair Value
<0.01 14.85 2.64--
Enterprise Value Multiple
0.20 -3.63 -0.90--
Enterprise Value
-16.78M 279.18M 78.25M--
EV to EBITDA
0.20 -3.63 -0.90--
EV to Sales
-15.20 286.34 0.00--
EV to Free Cash Flow
0.21 -4.26 -0.99--
EV to Operating Cash Flow
0.22 -4.54 -1.03--
Tangible Book Value Per Share
0.25 0.61 1.90--
Shareholders’ Equity Per Share
0.25 0.61 1.90--
Tax and Other Ratios
Effective Tax Rate
0.00 0.02 0.02--
Revenue Per Share
0.03 0.03 0.00--
Net Income Per Share
-2.16 -2.39 -3.31--
Tax Burden
1.00 0.98 0.98--
Interest Burden
1.03 1.04 1.01--
Research & Development to Revenue
61.42 57.40 0.00--
SG&A to Revenue
18.99 24.49 0.00--
Stock-Based Compensation to Revenue
9.37 13.01 0.00--
Income Quality
0.85 0.75 0.88--
Currency in USD